The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients
Source abstract
Abstract
Purpose: To evaluate the diagnostic effect of sequential detection of Adenosine deaminase (ADA) screening and T-SPOT assay on tuberculosis (TB) pleurisy in pleural effusion patients. Materials and methods: 248 pleural effusion patients (172 TB and 76 non-TB) were retrospectively analyzed in the study. The concentrations of ADA and lactate dehydrogenase (LDH) were measured in pleural fluids and serum samples of the patients. T-SPOTT assays were performed in pleural fluids. The relationship between ADA, T-SPOT and the occurrence of TB pleurisy was evaluated using logistic regression analysis. Results: The level of pleural ADA and positive rate of T-SPOT were all higher in TB pleurisy group than non-TB pleurisy group (p < .001). The positive rate of T-SPOT detection reached 98.83% in the TB pleurisy group while only 40.7% in non-TB pleurisy group (p < .001). Additionally, 8 patients (4.65%) in the TB pleurisy group showed the level of pleurisy ADA exceeded 40 IU/L while only one patient (1.31%) in the non-TB pleurisy group. Conclusion: The sequential detection of ADA screening and T-SPOT assay was found to be an accurate and rapid method for identifying TB pleurisy from pleural effusion, which would promote effective treatment.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Pleural and Pulmonary Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Respiration, Daping Hospital, Army Military Medical University
Funding
Chongqing Municipal People’s Livelihood Science and Technology Innovation grant
References (25)
Show source-provided references
1. 10.1016/S0140-6736(13)62078-410.1016/S0140-6736(13)62078-4 ↗
2. 10.21037/jtd.2016.05.8710.21037/jtd.2016.05.87 ↗
3. 10.1136/thoraxjnl-2011-20136310.1136/thoraxjnl-2011-201363 ↗
4. 10.1007/s00408-009-9165-310.1007/s00408-009-9165-3 ↗
5. 10.1378/chest.118.5.135510.1378/chest.118.5.1355 ↗
6. 10.1378/chest.109.1.15810.1378/chest.109.1.158 ↗
7. 10.1016/j.rmed.2007.12.00710.1016/j.rmed.2007.12.007 ↗
8. 10.1001/jama.293.22.275610.1001/jama.293.22.2756 ↗
9. Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection – United States, 2010. MMWR Recomm Rep. 2010;59:1–25.
10. 10.7326/0003-4819-149-11-200812020-0024810.7326/0003-4819-149-11-200812020-00248 ↗
11. 10.1164/rccm.201006-0974OC10.1164/rccm.201006-0974OC ↗
12. 10.1378/chest.06-227310.1378/chest.06-2273 ↗
13. 10.1016/j.jinf.2013.05.00910.1016/j.jinf.2013.05.009 ↗
14. 10.1183/09031936.0006730710.1183/09031936.00067307 ↗
15. 10.3760/cma.j.issn.0366-6999.2013002010.3760/cma.j.issn.0366-6999.20130020 ↗
16. 10.1371/journal.pone.003872910.1371/journal.pone.0038729 ↗
17. 10.1016/j.jmii.2010.04.00110.1016/j.jmii.2010.04.001 ↗
18. 10.1258/00045630376647701110.1258/000456303766477011 ↗
19. 10.1016/j.jinf.2014.12.01810.1016/j.jinf.2014.12.018 ↗
20. 10.1183/09031936.0000530910.1183/09031936.00005309 ↗
21. 10.3892/etm.2015.246310.3892/etm.2015.2463 ↗
22. 10.1309/LMFBRT05MWV3AYIM10.1309/LMFBRT05MWV3AYIM ↗
23. Zhu C, Liu Z, Li Z, et al. The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence setting. J Thorac Dis. 2014;6:713–719.
24. 10.1007/s15010-013-0478-z10.1007/s15010-013-0478-z ↗
25. 10.1111/j.1440-1843.2011.01941.x10.1111/j.1440-1843.2011.01941.x ↗